{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-103068","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2025-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.231923+00:00","generated_at":"2026-05-17T01:57:23.293768+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"INmune Bio to host Q3 2025 results conference call on October 30, 2025","bullets":["Company will report Q3 2025 financial results and provide corporate update on October 30, 2025 at 4:30 PM ET.","Dial-in details: 1-800-225-9448 (US), 1-203-518-9708 (international), Conference ID: INMUNE.","Webcast accessible via provided link; replay available through Nov 13 by dialing 1-844-512-2921 (PIN 11159914).","No financial results disclosed in this press release; results will be provided during the call."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-103068","json":"https://secwatch.observer/filing/0001213900-25-103068.json","markdown":"https://secwatch.observer/filing/0001213900-25-103068.md","text":"https://secwatch.observer/filing/0001213900-25-103068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025103068/0001213900-25-103068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025103068/ea0262255-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:57:23.293768+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}